Skip to main content
Premium Trial:

Request an Annual Quote

Bioline EPIK miRNA Select Kits

Bioline, a Meridian Bioscience company, has launched its EPIK miRNA Select assays worldwide. These assays were developed to study individual microRNA (miRNA) molecules. The individual assays use the same approach developed by MiRXES for the EPIK miRNA Panel assays; they employs miRNA-specific reverse transcriptase primers and hemi-nested real-time PCR primers along with Bioline reverse transcriptase, SensiSMART with SYBR Green, and highly optimized buffers. This combination of technology enables the assays to detect extremely low levels of miRNA with very high specificity, which makes it possible to discriminate between closely related miRNA sequences, the company said.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.